Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin
- 27 December 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 132 (2), 753-763
- https://doi.org/10.1007/s10549-011-1926-z
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim reportWorld Journal of Surgical Oncology, 2009
- All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II TrialBritish Journal of Cancer, 2009
- Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancerBreast Cancer Research and Treatment, 2007
- Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratioJournal of Translational Medicine, 2007
- Is Liver Resection Justified for Patients With Hepatic Metastases From Breast Cancer?Annals of Surgery, 2006
- Radiofrequency Ablation (RFA) as A Cytoreductive Strategy for Hepatic Metastasis from Breast CancerThe Annals of The Royal College of Surgeons of England, 2006
- Curative liver resection for metastatic breast cancerEuropean Journal of Surgical Oncology, 2000
- Hepatic resection in metastatic breast cancer: results and prognostic factorsEuropean Journal of Surgical Oncology, 2000
- The regional treatment of liver metastases from breast cancerJournal of Surgical Oncology, 1994